Article Details

Immunomic Therapeutics Announces License Agreement With Lineage Cell Therapeutics for ...

Retrieved on: 2021-04-20 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Immunomic Therapeutics Announces License Agreement With Lineage Cell Therapeutics for .... View article details on hiswai:

Excerpt

(NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell transplants for serious medical conditions. The ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up